B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. - Finckh,A.; Ciurea,A.; Brulhart,L. (Arthritis Rheum, 2007)